Researchers at the University of Cambridge have developed a new technique that uses light instead of toxic chemicals to transform complex drug molecules. This discovery has the potential to accelerate drug development and make the drug design process more efficient.
The study was published on March 12th. natural synthesisintroduces what the team calls an “anti-Friedelcrafts” reaction. Traditional Friedel-Crafts chemistry requires strong chemicals or metal catalysts and harsh laboratory conditions. Because of these requirements, reactions are typically carried out in the early stages of drug manufacturing, followed by many additional chemical steps to produce the final drug.
The new Cambridge method turns that process around by allowing researchers to make changes to drug molecules long after development.
LED-induced reactions form important chemical bonds
Instead of relying on heavy metal catalysts, the reaction is activated by LED lamps at ambient temperature. When light triggers a reaction, it initiates a self-sustaining chain process that forms carbon-carbon bonds under mild conditions without the use of toxic or expensive reagents.
In practical terms, this approach allows chemists to tailor complex molecules at the final stage of the drug development process, rather than taking them apart and rebuilding them piece by piece. Normal methods can take months.
“We have discovered a new way to make precise changes to complex drug molecules, particularly those that have until now been extremely difficult to modify,” said lead author and postdoctoral researcher David Verhey from St John’s College, Cambridge.
“Scientists may spend months rebuilding large portions of molecules just to test one small change. Now, instead of running a multi-step process on hundreds of molecules, scientists can start with a hit and make small modifications later.”
“This reaction allows scientists to make precise adjustments much later in the process under mild conditions and without relying on toxic or expensive reagents. This opens up areas of chemistry that were previously difficult to access and gives medicinal chemists a cleaner and more efficient tool to explore new drug versions.”
Reduce waste and achieve faster drug discovery
Reducing the number of synthetic steps reduces chemical usage, reduces energy consumption, and shrinks the environmental footprint of drug development. It also saves researchers valuable time.
This reaction is highly selective, allowing chemists to change specific parts of the molecule without affecting other sensitive regions. This precision is important because even small structural changes can affect how a drug works in the body, how it behaves biologically, or whether side effects occur.
At the heart of this breakthrough is addressing the fundamental chemical challenge of carbon-carbon bond formation. These bonds form the backbone of countless materials, including fuels, plastics, and complex biomolecules.
The technology also exhibits what chemists describe as “high functional group tolerance.” This means that you can change one region of the molecule while leaving other functional groups the same. For this reason, this reaction is particularly useful in late-stage optimization, the drug discovery stage where scientists fine-tune molecules to improve a drug’s performance.
Because this approach avoids heavy metals, harsh reaction conditions, and long synthetic routes, it also has the potential to reduce toxic waste and energy consumption in drug manufacturing. These environmental benefits are becoming increasingly important as the chemical industry strives to reduce its impact on the environment.
Inspired by sustainable chemistry research
Vahey works in a research group led by Professor Erwin Reisner at the University of Cambridge. Reisner’s team is known for developing chemical systems inspired by photosynthesis. Their research explores ways to harness sunlight to convert waste, water, and the greenhouse gas carbon dioxide into useful chemicals and fuels.
Reissner, the Yusuf Hameed Professor of Energy and Sustainability in the Department of Chemistry and lead author of the study, said the importance of this work lies in expanding what chemists can achieve under real-world conditions while aiming for greener manufacturing techniques.
“This is a new way to form fundamental carbon-carbon bonds, which is why the potential impact is so large. It also means chemists can avoid unwanted and inefficient drug modification processes.”
The researchers tested this reaction on a wide range of drug-like molecules and showed that it can also be adapted to continuous flow systems commonly used in industrial chemical production. Our collaboration with AstraZeneca has helped us assess whether this technology can meet the practical and environmental requirements of large-scale drug manufacturing.
“Transitioning the chemical industry to a sustainable industry is probably one of the most difficult parts of the entire energy transition,” Reissner explained.
Breakthroughs emerge from failed experiments.
This discovery, like many famous scientific advances such as X-rays, penicillin, Viagra, and modern weight loss drugs, began with an unexpected experimental result.
“Failure after failure. Then out of the chaos we found something unexpected: a real diamond in the rough. And it was all because of a failed control experiment,” Verhey said.
While testing photocatalysts, he removed the photocatalyst during a control experiment and discovered that the reaction worked just as well, and in some cases even better, without the photocatalyst.
At first it seemed that the unusual product was a mistake. Rather than ignore it, researchers decided to investigate further. According to Reissner, recognizing the significance of unexpected results is an important part of scientific discovery.
“Recognizing the value of unexpected events is probably one of the key characteristics of successful scientists,” he said.
AI helps predict new chemical reactions
“We generate huge amounts of data and are increasingly using artificial intelligence to help analyze it. We have algorithms that can predict reactivity. AI is helpful because chemists don’t have to do endless trial and error, but algorithms just follow the rules they’re given. We still need humans to look at something that looks wrong and ask whether it might actually be something new.”
In this case, Vahey recognized the potential significance of the unexpected result and investigated it further.
“David could have written it off as a failure of control,” Reisner said. “Instead, he stopped and thought about what he was seeing. Discovery happens in those moments when you choose to investigate rather than ignore.”
After uncovering the chemistry behind the reaction, the team deployed a machine learning model developed with Trinity College, Dublin, to predict where the reaction would occur in entirely new molecules that had never been tested in the lab.
By learning patterns from known chemical reactions, AI systems can simulate possible outcomes before performing an experiment. This allows researchers to identify promising molecules more quickly and with much less trial and error.
For Vahey, this discovery provides scientists with valuable new capabilities for drug discovery and development.
“What industry and other researchers do with it next will be the impact going forward. For us, the lab is mostly about average or bad days. The good days are very good days.”
Reisner added, “Chemists only need one or two good days a year. Those days can come from failed experiments.”
10 famous accidental scientific discoveries 1. X-ray (1895)
Wilhelm Conrad Röntgen discovered X-rays while studying the flow of electric current through glass tubes. He notices that a nearby screen unexpectedly begins to glow, revealing a new type of radiation that allows doctors to see inside the human body without surgery.
2. Radioactivity (1898)
Marie Curie observed that certain uranium minerals produce far more radiation than can be explained by uranium alone. This amazing discovery led to the discovery of polonium and radium and helped establish the fields of nuclear physics and chemistry.
3. Vulcanized rubber (1839)
Charles Goodyear discovered the vulcanization reaction when a mixture of natural rubber and sulfur was accidentally dropped onto a hot surface. Instead of melting, the rubber became strong and elastic. This process made rubber commercially viable and ultimately made possible the development of tires and many other products.
4. Penicillin (1928)
Alexander Fleming discovered penicillin after mold accidentally contaminated a laboratory dish, killing the surrounding bacteria. This discovery led to the first widely used antibiotics and transformed modern medicine.
5. Teflon (1938)
Chemist Roy Plunkett accidentally created Teflon while experimenting with refrigerant gas. This unexpected material was found to be extremely slippery and heat resistant, and later became widely used in nonstick cookware and industrial applications.
6. Superglue (1942)
Harry Coover had been trying to develop a transparent plastic, but instead he developed a substance that instantly adhered to almost any surface. It was later sold as an instant adhesive and became widely used in homes, manufacturing, and medical settings.
7. LSD (1943)
Swiss chemist Albert Hofmann accidentally absorbed a small amount of a compound he had synthesized and experienced its powerful psychological effects. This substance, lysergic acid diethylamide (LSD), later played an important role in neuroscience research and became controversial in popular culture.
8. Pulsars (1967)
While analyzing telescope data, graduate student Jocelyn Bell Burnell noticed a repeating radio signal. Initially thought to be interference, the signal turned out to be the first evidence of a pulsar, a rapidly rotating neutron star, opening up a new field of astrophysics.
9. Viagra (1990s)
Researchers at Pfizer were studying a drug aimed at treating angina pectoris when participants reported unexpected side effects. This compound was later developed as Viagra and is now widely prescribed for erectile dysfunction.
10. Weight Loss Injection (2021)
Scientists developing treatments for type 2 diabetes have discovered that drugs that mimic the GLP-1 hormone also cause significant weight loss. Drugs such as Ozempic and Munjaro, originally created for diabetes, were later developed to treat obesity and revolutionized the approach to weight management.
